173 An in vivo CRISPR/Cas9 screening platform to identify T cell enhancing edits in distinct solid tumor microenvironments

• Jeff Jones,
• Amy Becker,
• Troy Luster,
• Ishina Balwani,
• Nachiket Shevale,
• Jingwei Sun,
• Erica Del Aguila,
• Srijani Sridhar,
• Nishit Patel,
• Daniel O’Connell,
• Reynald Lescarbeau,
• Birgit Schultes

Affiliations

Jeff Jones

APHA Carmarthen Veterinary Investigation Centre, Jobs Well Road, Johnstown, Carmarthen SA31 3EZ

Amy Becker

Intellia Therapeutics, Cambridge, MA, USA

Troy Luster

Intellia Therapeutics, Cambridge, MA, USA

Ishina Balwani

Intellia Therapeutics, Cambridge, MA, USA

Nachiket Shevale

Intellia Therapeutics, Cambridge, MA, USA

Jingwei Sun

Intellia Therapeutics, Cambridge, MA, USA

Erica Del Aguila

Intellia Therapeutics, Cambridge, MA, USA

Srijani Sridhar

Intellia Therapeutics, Cambridge, MA, USA

Nishit Patel

Intellia Therapeutics, Cambridge, MA, USA

Daniel O’Connell

Intellia Therapeutics, Cambridge, MA, USA

Reynald Lescarbeau

Intellia Therapeutics, Cambridge, MA, USA

Birgit Schultes

Intellia Therapeutics, Cambridge, MA, USA